Kenozole-BG Cream

Introduction

Kenozole-BG is a prescription medication that combines three active ingredients: Ketoconazole, Beclometasone, and Gentamicin. It is commonly used in the treatment of various skin conditions.

Uses

Kenozole-BG is prescribed for the treatment of fungal infections of the skin, such as athlete’s foot, jock itch, and ringworm. It is also effective in managing inflammatory skin conditions, such as eczema and dermatitis. Additionally, it is used to treat bacterial skin infections.

Dosage and Administration

Kenozole-BG should be applied to the affected area of the skin as directed by your healthcare provider. Clean and dry the affected area before applying the cream. Gently massage a thin layer of the cream into the skin until it is evenly distributed. Wash your hands after each application. The frequency and duration of use will depend on the specific condition being treated. Follow your healthcare provider’s instructions carefully.

Mechanism of Action

Ketoconazole, one of the active ingredients in Kenozole-BG, is an antifungal agent that works by inhibiting the growth of fungus on the skin. Beclometasone is a corticosteroid that helps reduce inflammation and itching. Gentamicin is an antibiotic that fights bacteria. Together, these ingredients work synergistically to treat both fungal and bacterial infections of the skin.

Side Effects

Common side effects may include skin irritation, burning, itching, or redness at the application site. These side effects are usually mild and temporary. If you experience any severe or persistent side effects, such as allergic reactions (e.g., rash, swelling, difficulty breathing) or signs of skin infection (e.g., increased pain, pus, worsening redness), seek medical attention immediately.

Drug Interactions

inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins. Certain medications may interact with Kenozole-BG and affect its effectiveness or increase the risk of side effects. Be sure to discuss any potential drug interactions with your healthcare provider.

Precautions

Before using Kenozole-BG, inform your healthcare provider about any allergies or sensitivities you may have. Avoid contact with the eyes, mouth, or other mucous membranes. If accidental contact occurs, rinse thoroughly with water. Kenozole-BG should not be used on broken or infected skin without the supervision of a healthcare professional. Avoid prolonged use of the cream without medical guidance.

Storage

Kenozole-BG should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets. Do not freeze the cream. Check the expiration date before using and discard any expired medication.

Patient Tips

• Follow the instructions provided by your healthcare provider for the application of Kenozole-BG.
• Avoid using excessive amounts of the cream, as it may increase the risk of side effects.
• If your symptoms do not improve or worsen after using the cream, consult your healthcare provider.
• complete the full course of treatment as prescribed, even if your symptoms improve.
• If you have any concerns or questions about your treatment, do not hesitate to reach out to your healthcare provider for clarification.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Beclometasone inhalers: a steroid medicine to treat asthma and COPD (NHS UK) [Accessed 29 Jun. 2024] (online) Available at:
• Beclometasone dipropionate 0.25 mg/g Cream (Health Professionals SmPC) Available at:
• Beclometasone (International database) (Drugs.com) [Accessed 19 Jun. 2024] (online) Available at:
• gentamicin (RX) [Accessed 2 Jun. 2024] (online) Available at:
• Beclomethasone Nasal Spray (MedlinePlus) [Accessed 19 Jun. 2024] (online) Available at:
• [No authors listed] Beclometasone oral–DOR BioPharma. Drugs R D. 2007;8(2):91-4. doi: 10.2165/00126839-200708020-00003. [Accessed 14 Jun. 2024] Available at: